FY2026-H1 delivered higher revenue and profit, with progress against the full-year forecast reaching 63.2% for revenue and 80.5% for operating profit. In Q3, the focus will be whether the agrochemicals business remains strong and whether the full-year forecasts of ¥52.0 billion in revenue and ¥5.2 billion in operating profit can be maintained.
All recorded disclosures and news since the latest annual or semiannual filing. Switching watchpoints keeps the full history. Select an item to inspect its source.2026-07-10 〜 2026-10-25 · 25 of 25 items
Scroll the timeline →
Will cumulative Q3 revenue reach at least ¥39.0 billion, exceeding simple 75% progress?
Is the company on track to secure the ¥19,151 million in revenue needed to achieve the full-year forecast after H1?
Can the company add the ¥1,016 million in operating profit and ¥1,443 million in ordinary profit needed after H1?
Will the full-year forecasts of ¥52,000 million in revenue, ¥5,200 million in operating profit and ¥6,100 million in ordinary profit be maintained?
The company's ongoing themes and initiatives this watchpoint touches on.
FY2026-H1 revenue was ¥32,849 million, up 7.1% year on year, operating profit was ¥4,184 million, up 14.4%, ordinary profit was ¥4,657 million, up 17.6%, and net profit attributable to owners of the parent was ¥3,380 million, up 20.7%. From Q1 through the cumulative Q2 period, revenue increased from ¥16,243 million to ¥32,849 million, while operating profit rose from ¥2,286 million to ¥4,184 million.
Progress against the full-year forecasts was 63.2% for revenue, 80.5% for operating profit, 76.3% for ordinary profit and 75.8% for net profit attributable to owners of the parent. Against the revenue forecast of ¥52,000 million, a further ¥19,151 million is required. The corresponding amounts are ¥1,016 million against the ¥5,200 million operating profit forecast, ¥1,443 million against the ¥6,100 million ordinary profit forecast, and ¥1,080 million against the ¥4,460 million net profit forecast.
The main reason profit progress is substantially ahead of revenue progress is higher revenue and improved margins in the agrochemicals business. H1 operating profit in that business was ¥2,673 million, up 56.1% year on year. The company has also identified a lower fixed-cost ratio resulting from higher production volumes as a factor behind past margin improvements. Ordinary profit included a ¥27 million foreign exchange gain, while interim net profit included a ¥237 million gain on the sale of investment securities. The sustainability of earnings excluding the uplift from non-operating and extraordinary items therefore also needs to be assessed.
In Q3, cumulative revenue of at least ¥39,000 million will be checked as a simple benchmark for quarterly progress. However, agrochemicals sales include the impact of orders brought forward, so it is necessary to assess not only the headline progress rate but also how much of the domestic rice-paddy and horticultural products and overseas sales reflected temporary pull-forward, and whether margin improvement toward the full-year operating profit forecast of ¥5,200 million is continuing.
Confirmed
Nine-month cumulative revenue was ¥44,924 million, or 86.4% of the full-year forecast of ¥52,000 million, while operating profit was ¥5,408 million, reaching 104.0% of the full-year forecast of ¥5,200 million. The agrochemicals business also continued to post higher revenue and operating profit, and the full-year earnings forecast was left unchanged, confirming that the strong first-half progress toward the full-year targets has continued.
JPY million
Select a value or step to inspect its source.
Ordered by date. Disclosures and financial records differ from news and company threads; open each source to inspect it.
2026-10-09
2026-10-09
The prior-year comparison for this event
2025-10-10 disclosed · In ¥ millions; each quarter is cumulative from the start of the fiscal year. EPS is in yen.
Latest available: FY2026 Q3
Net salesBusiness scale
41,578JPY m
YoY unavailableOperating profitCore earnings
4,846JPY m
YoY unavailableNewest first. The highlighted column is this event’s comparison. YoY uses the same period and accounting basis.
| Metric | FY2026 Q3 | FY2026 Q2 | FY2026 Q1 | FY2025 full year | FY2025 Q3Comparison | FY2025 Q2 | FY2025 Q1 | FY2024 full year |
|---|---|---|---|---|---|---|---|---|
| Net sales | 44,924↗ +8.0% YoY | 32,849↗ +7.1% YoY | 16,243↗ +5.8% YoY | 49,125↗ +6.3% YoY | 41,578YoY unavailable | 30,666YoY unavailable | 15,353YoY unavailable | 46,195YoY unavailable |
| Operating profit | 5,408↗ +11.6% YoY | 4,184↗ +14.4% YoY | 2,286↗ +20.5% YoY | 4,913↗ +8.2% YoY | 4,846YoY unavailable | 3,657YoY unavailable | 1,897YoY unavailable | 4,540YoY unavailable |
| Ordinary profit | 6,268↗ +12.3% YoY | 4,657↗ +17.6% YoY | 2,436↗ +19.6% YoY | 6,083↗ +6.9% YoY | 5,580YoY unavailable | 3,959YoY unavailable | 2,036YoY unavailable | 5,691YoY unavailable |
| Net income | 4,504↗ +9.1% YoY | 3,380↗ +20.7% YoY | 1,734↗ +22.5% YoY | 4,452↗ +11.1% YoY | 4,127YoY unavailable | 2,800YoY unavailable | 1,415YoY unavailable | 4,006YoY unavailable |
| Earnings per share | 174.3↗ +11.2% YoY | 131.1↗ +23.5% YoY | 67.28↗ +25.6% YoY | 169.9↗ +14.7% YoY | 156.81YoY unavailable | 106.18YoY unavailable | 53.55YoY unavailable | 148.15YoY unavailable |